CAMBRIDGE, Mass., July 17 /PRNewswire/ -- Metabolix, Inc. announced
today that it has filed a registration statement with the Securities and
Exchange Commission for the initial public offering of its common stock.
Piper Jaffray & Co. will be the sole book-running manager for the offering.
Jefferies & Company, Inc., Thomas Weisel Partners LLC and Ardour Capital
Investments, LLC will be co-managers for the offering.
A registration statement relating to these securities has been filed
with the Securities and Exchange Commission but has not yet become
effective. These securities may not be sold nor may offers to buy be
accepted prior to the time that the registration statement becomes
effective. This news release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation,
or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The offering will be
made only by means of a prospectus. When available, copies of the
preliminary prospectus relating to this offering may be obtained from Piper
Jaffray & Co., 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402.
Metabolix is a biotechnology company that develops and plans to
commercialize environmentally sustainable, economically attractive
alternatives to petrochemical-based plastics, fuels and chemicals.
James J. Barber
President & CEO
+1-617-492-0505 ext. 225
Thomas G. Auchincloss, Jr.
Chief Financial Officer
+1-617)-492-0505 ext. 221
SOURCE Metabolix, Inc.